10月30日，药明康德（02359.HK）股价盘中大跌5.15%，引发市场关注。消息面上，公司于近日公告称，实际控制人控制的股东计划在未来3个月内减持不超过公司总股本2%的股份。
根据公告，减持原因为股东自身资金需求。减持计划将于公告披露15个交易日后的3个月内进行，减持方式包括集中竞价和大宗交易。拟减持股份数量不超过59,675,143股，约占公司总股本的2%。截至公告日，这些股东合计持有公司A股股份543,364,675股，占总股本的18.211%。
分析人士指出，虽然此次减持规模相对有限，但作为公司实际控制人控制的股东选择减持，可能引发市场对公司未来发展前景的担忧，从而导致股价下跌。不过，公司表示本次减持计划不会导致公司控制权发生变更。投资者应密切关注后续减持进展及其对公司股价的影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.